19.06.2014 • NewsMergers & Acquisitions (M&A)AllerganBotox

Valeant Begins Exchange Offer for Allergan

Canada's Valeant Pharmaceuticals is taking its hostile $50.8 billion bid to acquire Botox manufacturer Allergan directly to shareholders.

Backed by activist shareholder Bill Ackman's Pershing Square Capital Management, Allergan's biggest shareholder with 9.7%, announced on June 18 it had begun an exchange offer for the California company.

Allergan shareholders are being given the opportunity to trade each share for $72 in cash and 0.83 Valeant share, or all cash or all stock.

Allergan said its board would review the exchange offer. On June 10, it rejected the bid, which contained the same major terms.

Resolving the battle could be positive for Valeant, given the toll it has taken on the company's shares and its potential missed opportunities while focused on Allergan, one analyst told the news agency Reuters.

Another analyst suggested that Allergan may make an offensive move against the hostile bid by bidding for Ireland-based drugmaker Shire - a deal that could be more attractive than Valeant's proposal.

Such an acquisition would give Allergan shareholders sales diversification, sustainable organic growth and other benefits and spare them the risk of holding Valeant shares, the analyst said.

Valeant's offer will expire on Aug. 15, unless extended.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.